Back to 
Nuveen Asset Management, LLC
Nuveen Asset Management, LLC
KPTI
Showing 0 of 21 quarters
Position history for Nuveen Asset Management, LLC's holdings in Karyopharm Therapeutics Inc.
No. Nuveen Asset Management exited its KPTI (Karyopharm Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 492,365 shares worth $743,471. Nuveen Asset Management first reported KPTI in Q2 2019 and held it in 20 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.